Delivery Order SPE2DB20D3101-SPE2DB25FRRD6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a ceiling value of $11,498.68. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and is scheduled for completion by August 21, 2025. The award supports pharmaceutical procurement for federal medical needs, with performance occurring at AmerisourceBergen's corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a ceiling value of $4,628.35. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance location...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Carvedilol ER 40 mg capsules in quantities of 30 per unit, with a contract ceiling value of $4,842.98. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 29, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count) with a ceiling value of $16,311.04. This competitive, firm fixed-price delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This award is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $1,401.21 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units). This contract is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Carvedilol ER 40 mg capsules in quantities of 30 per unit, with a contract ceiling value of $2,692.51. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,655.31 to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $50,589.89 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price, competitively awarded delivery order was issued without set-aside designation and is to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $4,578.12 to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) valued at $28,718.73. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by August 4, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRRD6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a ceiling value of $6,612.84. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under a larger federal contract vehicle supporting the Defense Logistics Agency's medical supply chain operations. This award is a child contract issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company competitively secured this prime IDV as a comprehensive global pharmaceutical support vehicle, enabling it to supply a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 7/28/25 |